TCF7L2 rs4950928: What Your Genotype Means for Diabetes Risk
The rs4950928 variant is a common genetic marker located within the TCF7L2 gene. It is widely recognized in scientific literature for its strong statistical association with type 2 diabetes susceptibility.
What each genotype means
Baseline diabetes risk
This genotype is considered the baseline or non-risk state for this specific variant. Research indicates that individuals with this genotype do not carry the specific genetic association linked to increased type 2 diabetes susceptibility often observed with the T allele. Please note that diabetes risk is complex and influenced by many genetic and environmental factors.
This is a common genotype found across most global populations.
Increased diabetes susceptibility
Carrying one copy of the T allele is associated with a statistically higher risk of developing type 2 diabetes compared to those without it. Studies suggest this variant may influence pancreatic beta-cell function and insulin secretion. You should discuss your overall metabolic health and diabetes screening with your clinician.
This is a common genotype observed frequently in many ancestral groups.
Elevated diabetes susceptibility
Carrying two copies of the T allele is associated with a stronger statistical predisposition to type 2 diabetes compared to the CC or CT genotypes. Research suggests this may be linked to altered TCF7L2 expression in the pancreas, which can affect insulin production. It is recommended to maintain a healthy lifestyle and consult with a healthcare provider regarding regular blood glucose monitoring.
This genotype is present in a significant portion of the population, though frequencies vary by ancestry.
What is rs4950928 and Where Does It Sit?
The rs4950928 variant is a single nucleotide polymorphism (SNP) located within the TCF7L2 (Transcription Factor 7 Like 2) gene on chromosome 10. In genomics, a SNP represents a variation at a single position in the DNA sequence among individuals. When researchers study SNPs, they are looking at specific letters in the genetic code—in this case, either a Cytosine (C) or a Thymine (T)—that differ between people. rs4950928 is located in a non-coding region of the TCF7L2 gene, meaning it does not provide direct instructions for making a protein itself. Instead, variants in these regions often function as regulatory elements, potentially influencing when, where, and how much of the TCF7L2 protein is produced. Because this region is highly conserved across different human populations, researchers use this marker to track how specific inherited patterns may correlate with observable biological traits, such as blood glucose regulation and metabolic health markers.
The Role of the TCF7L2 Gene
The TCF7L2 gene provides instructions for creating a transcription factor protein that plays a central role in the Wnt signaling pathway. This pathway is a fundamental biological communication system that helps regulate cell growth, specialization, and movement during development, and it remains active in many adult tissues. In the context of metabolism, TCF7L2 is highly expressed in the pancreas, where it is critical for the function of beta cells. These are the specialized cells responsible for producing and secreting insulin in response to blood sugar levels. By regulating the expression of genes involved in insulin secretion and glucose homeostasis, the TCF7L2 protein helps the body maintain stable blood sugar. Because of its pivotal role in pancreatic function, any genetic variation that alters the regulation of TCF7L2 can theoretically impact how effectively the body manages insulin production, which is why it has become a primary focus of diabetes-related genomic research.
Research and Statistical Associations
The association between TCF7L2 variants and type 2 diabetes is among the most replicated findings in the history of diabetes genetics. Large-scale Genome-Wide Association Studies (GWAS) have consistently linked rs4950928 and neighboring variants in TCF7L2 to an increased risk of developing type 2 diabetes across diverse populations. The evidence strength for this association is considered strong, as it has been validated in hundreds of thousands of participants worldwide. It is important to note that these studies identify statistical associations, not direct causation. Having a specific genotype at this position does not guarantee that an individual will develop diabetes, nor does it mean that those without the variant are immune. Rather, the variant acts as a risk allele that contributes to an individual's overall genetic predisposition. When combined with lifestyle factors such as diet, physical activity, and body mass index, these genetic markers help researchers build a more comprehensive picture of the complex, polygenic nature of metabolic disease.
What You Can and Cannot Do With This Information
Information about your genotype for rs4950928 provides insight into your genetic predisposition, but it is not a diagnostic tool. You cannot use this information to determine if you have or will develop type 2 diabetes, as diabetes is a multifactorial condition influenced by diet, exercise, environment, and thousands of other genetic markers. Knowing your genotype does not replace routine medical screenings, such as fasting blood glucose or HbA1c tests, which are the current clinical standards for assessing metabolic health. If you are concerned about your diabetes risk, the most actionable step is to discuss your family history and personal health goals with a healthcare provider. They can provide personalized advice on screenings and lifestyle adjustments. Never use genetic information to make decisions about medications or dietary changes without first consulting with a clinician or pharmacist, as they can provide guidance grounded in your total health picture.
How common is this variant?
The rs4950928 variant is common across most human populations, though its exact frequency varies by ancestry. Because it is a common variant, the majority of the human population carries at least one copy.
Frequently asked questions
Is rs4950928 a cause of type 2 diabetes?
No, rs4950928 is not a direct cause of diabetes. It is a genetic marker associated with an increased statistical susceptibility, meaning it is one of many factors that can influence how your body regulates blood sugar.
Can I use a DNA test to predict if I will get diabetes?
Direct-to-consumer genetic tests cannot predict if you will develop diabetes. Type 2 diabetes is complex and influenced by many environmental and lifestyle factors that are far more predictive than any single SNP.
Should I change my diet based on this SNP?
There is no one-size-fits-all diet based on rs4950928. If you are concerned about diabetes risk, consult a registered dietitian or your physician to create a nutrition plan tailored to your overall health needs and medical history.
Where can I find my genotype for this SNP?
Your genotype for rs4950928 may be included in reports from various consumer genetic testing companies. You can find this information by looking for the rsID in your raw data file, though interpretation should always be discussed with a qualified professional.
Sources & further reading
Educational information only, last refreshed 10/4/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs4950928?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in TCF7L2
This variant in the TCF7L2 gene is one of the strongest genetic risk factors for the development of type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 consistently associated with altered pancreatic beta-cell function and predisposition to type 2 diabetes.
Resides within the TCF7L2 genomic locus, which is strongly linked to altered glucose regulation and type 2 diabetes susceptibility.
This variant is a well-established marker within the TCF7L2 locus, which is recognized as the most potent genetic risk factor for type 2 diabetes across multiple ethnic groups.
Variant in TCF7L2 strongly associated with type 2 diabetes risk and modulation of glycemic response to dietary fiber.
Intronic variant in TCF7L2 strongly associated with increased risk of Type 2 Diabetes through impaired insulin secretion.